COPD: Novel Therapeutics and Management Strategies

Understanding current clinical trial guidelines for COPD and emphasis on new therapies and issues surrounding the management of COPD and management of exacerbations of COPD
 
 
Final-banner
Final-banner
June 13, 2012 - PRLog -- SMi is proud to present their 4th annual conference on COPD. With presentations from the biggest players in the field, this year’s event promises to be a perfect forum for discussion and debate with key opinion leaders from industry and academia.

Key Benefits of Attending:
•  Hear from leading industry professionals on the current clinical trials process and
rapid proof of concept studies
Consider developments in the modelling and management of exacerbations of COPD
•  Evaluate unique complexities of COPD pathophysiology - compare and contrast
COPD with Asthma to improve your understanding of what makes COPD unique and
needing of particular attention
•  Develop combination and oxygen therapies within COPD - learn about triple
therapies and novel therapies within the treatment of COPD
•  Analyse all phases of the discovery process, from pre-clinical modelling, phase 2
studies all the way through to modelling clincal outcomes
•  Network with and learn from key industry professionals and research leading academics
•  Discuss the latest in health economics for COPD drugs with internationally recognized key opinion leaders

For more information visit http://www.smi-online.co.uk/goto/copd-conference19.asp or call Ninica Hussain on +44 0207 827 6186 email nhussain@smi-online.co.uk
End
Source:SMi Group
Email:***@smi-online.co.uk Email Verified
Tags:Copd, Exacerbation, Inhale, Lung, Asthma
Industry:Pharmaceutical
Location:United Kingdom
Subject:Products
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Trending
Daily News
Weekly News



Like PRLog?
9K2K1K
Click to Share